2025. GLP-1 Receptor Agonists and Substance Use Disorders: A Public Health Opportunity with Emerging Safety Concerns. Epidemiology, Biostatistics, and Public Health. 21, 1 (Nov. 2025). DOI:https://doi.org/10.54103/2282-0930/29800.